Replies to post #181 on Profound Medical Corp (PROF)

[chilar4567]

I didn't study the details but think this is significent
"Profound is also commercializing Sonalleve(R), an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases. Sonalleve(R) has also been approved by the China Food and Drug Administration for the non-invasive treatment of uterine fibroids. The Company is in the early stages of exploring additional potential treatment markets for Sonalleve(R) where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy."
I grabbed a bunch today.

[Lazerking40]

From their PR from today:

"Each Unit will consist of one common share (a “Common Share”) and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”) of the Company. Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of two years following the closing date of the Offering and the Concurrent U.S. Private Offering at an exercise price of $1.55 per Warrant Share, subject to adjustment in certain events."